Barclays’s T2 Biosystems, Inc TTOO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1
| Closed | – | – | 5676 |
|
|
2025
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 5699 |
|
|
2024
Q4 | $0 | Sell |
1
-100
| -99% | -$84 | ﹤0.01% | 5596 |
|
|
2024
Q3 | $199 | Buy |
+101
| New | +$383 | ﹤0.01% | 5166 |
|
|
2021
Q4 | – | Sell |
-6
| Closed | -$27K | – | 4842 |
|
|
2021
Q3 | $27K | Buy |
6
+4
| +200% | +$20.1K | ﹤0.01% | 4305 |
|
|
2021
Q2 | $9K | Sell |
2
-28
| -93% | -$181K | ﹤0.01% | 4683 |
|
|
2021
Q1 | $241K | Buy |
+30
| New | +$318K | ﹤0.01% | 3621 |
|
|
2019
Q4 | – | Sell |
-13
| Closed | -$162K | – | 6929 |
|
|
2019
Q3 | $162K | Buy |
13
+1
| +8% | +$8.03K | ﹤0.01% | 5123 |
|
|
2019
Q2 | $103K | Buy |
12
+10
| +500% | +$117K | ﹤0.01% | 5674 |
|
|
2019
Q1 | $23K | Sell |
2
-3
| -60% | -$51K | ﹤0.01% | 6304 |
|
|
2018
Q4 | $69K | Sell |
5
-7
| -58% | -$164K | ﹤0.01% | 5285 |
|
|
2018
Q3 | $445K | Buy |
12
+8
| +200% | +$263K | ﹤0.01% | 4371 |
|
|
2018
Q2 | $154K | Sell |
4
-1
| -20% | -$38K | ﹤0.01% | 4940 |
|
|
2018
Q1 | $158K | Sell |
5
-2
| -29% | -$53.8K | ﹤0.01% | 5033 |
|
|
2017
Q4 | $138K | Buy |
+7
| New | +$145K | ﹤0.01% | 4993 |
|
|
2017
Q3 | – | Sell |
-5
| Closed | -$75K | – | 7102 |
|
|
2017
Q2 | $75K | Buy |
+5
| New | +$100K | ﹤0.01% | 5109 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6654 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 6512 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6472 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 6507 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 6710 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 7119 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 6712 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 6782 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 6795 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 7431 |
|
Barclays's TTOO Position: Q2 2025 in Review
Barclays sold out of T2 Biosystems, Inc (TTOO) in Q2 2025, closing a stake of 1 share.
Barclays first reported a position in TTOO in Q2 2017 and held it in 15 quarters. The position peaked at $445K in Q3 2018. 1 fund tracked by Wall St. Rank holds TTOO as of Q2 2025.
- Barclays reported no remaining T2 Biosystems, Inc position as of Q2 2025 after selling out during the quarter.
- Barclays sold 1 T2 Biosystems, Inc share in Q2 2025.
- Barclays first reported a position in T2 Biosystems, Inc in Q2 2017 and held it in 15 quarters.
- Barclays's T2 Biosystems, Inc position peaked at $445K in Q3 2018.
- 1 fund tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2025.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.